Embla Medical Statistics
Total Valuation
Embla Medical has a market cap or net worth of 2.13 billion. The enterprise value is 2.59 billion.
| Market Cap | 2.13B |
| Enterprise Value | 2.59B |
Important Dates
The last earnings date was Tuesday, July 22, 2025.
| Earnings Date | Jul 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 426.73M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.80% |
| Shares Change (QoQ) | -3.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 160.29M |
Valuation Ratios
The trailing PE ratio is 29.07 and the forward PE ratio is 23.42.
| PE Ratio | 29.07 |
| Forward PE | 23.42 |
| PS Ratio | 2.43 |
| PB Ratio | 2.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.59 |
| P/OCF Ratio | 17.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.10, with an EV/FCF ratio of 26.33.
| EV / Earnings | 35.46 |
| EV / Sales | 3.02 |
| EV / EBITDA | 15.10 |
| EV / EBIT | 20.85 |
| EV / FCF | 26.33 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.79 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 3.35 |
| Debt / FCF | 5.74 |
| Interest Coverage | 5.72 |
Financial Efficiency
Return on equity (ROE) is 9.27% and return on invested capital (ROIC) is 5.58%.
| Return on Equity (ROE) | 9.27% |
| Return on Assets (ROA) | 4.66% |
| Return on Invested Capital (ROIC) | 5.58% |
| Return on Capital Employed (ROCE) | 8.47% |
| Revenue Per Employee | 218,378 |
| Profits Per Employee | 18,285 |
| Employee Count | 4,061 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.15 |
Taxes
In the past 12 months, Embla Medical has paid 22.62 million in taxes.
| Income Tax | 22.62M |
| Effective Tax Rate | 23.48% |
Stock Price Statistics
The stock price has decreased by -7.78% in the last 52 weeks. The beta is 0.58, so Embla Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -7.78% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 5.69 |
| Relative Strength Index (RSI) | 39.62 |
| Average Volume (20 Days) | 10,321 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Embla Medical had revenue of 873.51 million and earned 73.14 million in profits. Earnings per share was 0.17.
| Revenue | 873.51M |
| Gross Profit | 547.98M |
| Operating Income | 120.62M |
| Pretax Income | 96.35M |
| Net Income | 73.14M |
| EBITDA | 141.75M |
| EBIT | 120.62M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 94.12 million in cash and 565.69 million in debt, giving a net cash position of -471.58 million.
| Cash & Cash Equivalents | 94.12M |
| Total Debt | 565.69M |
| Net Cash | -471.58M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 835.92M |
| Book Value Per Share | 1.95 |
| Working Capital | 198.70M |
Cash Flow
In the last 12 months, operating cash flow was 119.55 million and capital expenditures -21.06 million, giving a free cash flow of 98.49 million.
| Operating Cash Flow | 119.55M |
| Capital Expenditures | -21.06M |
| Free Cash Flow | 98.49M |
| FCF Per Share | n/a |
Margins
Gross margin is 62.73%, with operating and profit margins of 13.81% and 8.37%.
| Gross Margin | 62.73% |
| Operating Margin | 13.81% |
| Pretax Margin | 11.03% |
| Profit Margin | 8.37% |
| EBITDA Margin | 16.23% |
| EBIT Margin | 13.81% |
| FCF Margin | 11.28% |
Dividends & Yields
Embla Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.80% |
| Shareholder Yield | 0.80% |
| Earnings Yield | 3.44% |
| FCF Yield | 4.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Embla Medical has an Altman Z-Score of 2.99 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.99 |
| Piotroski F-Score | 6 |